2002•American Heart JournalRequires access

Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis

Hirotoshi Kamishirado, Teruo Inoue, Keiichi Mizoguchi, Toshihiko Uchida, Toshiyuki Nakata, Masashi Sakuma, Kan Takayanagi, Shigenori Morooka

Open publisher page 28 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 28 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Cilostazol, Ticlopidine, Restenosis, Coronary stent, Randomized controlled trial, Stent, Cardiology

Back to paper search Browse research topics Original source

Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis — Research Paper | ScholarLens